|Articles|October 23, 2019
FDA Method for Determination of NDMA in Ranitidine
Author(s)VWR International Ltd
FDA recently posted an LC–HRMS method using the novel ACE3 C18-AR column, which can be used by regulators to detect “probable human carcinogen” NDMA in ranitidine.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Volatile Organic Compound Profiling of Commercial Kombucha Using GC-TOF-MS and GC×GC-TOF-MS
2
A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?
3
Leaks and Obstructions: Troubleshooting Common Problems Close to the Point of Sample Injection
4
Deep In The Heart of Texas: Pittcon 2026
5